Shamrock Asset Management’s Novartis NVS Stock Holding History

Shamrock Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$809K	Sell	9,307 -251	-3%	-$22.5K	0.63%	42
2019 Q2	$873K	Sell	9,558 -783	-8%	-$66.3K	0.62%	40
2019 Q1	$891K	Sell	10,341 -42	-0.4%	-$3.37K	0.71%	26
2018 Q4	$798K	Sell	10,383 -21	-0.2%	-$1.64K	1.21%	21
2018 Q3	$803K	Hold	10,404	–	–	0.51%	40
2018 Q2	$704K	Hold	10,404	–	–	0.43%	50
2018 Q1	$716K	Sell	10,404 -419	-4%	-$31.9K	0.43%	48
2017 Q4	$814K	Hold	10,823	–	–	0.48%	41
2017 Q3	$833K	Sell	10,823 -229	-2%	-$17.3K	0.53%	36
2017 Q2	$825K	Sell	11,052 -388	-3%	-$27.5K	0.52%	39
2017 Q1	$761K	Sell	11,440 -1,581	-12%	-$105K	0.47%	43
2016 Q4	$850K	Sell	13,021 -1,219	-9%	-$79.1K	0.52%	37
2016 Q3	$1.01M	Sell	14,240 -147	-1%	-$10.7K	0.58%	22
2016 Q2	$1.06M	Sell	14,387 -278	-2%	-$19.2K	0.62%	19
2016 Q1	$952K	Sell	14,665 -8,224	-36%	-$559K	0.56%	16
2015 Q4	$1.76M	Sell	22,889 -1,027	-4%	-$81.6K	0.99%	8
2015 Q3	$1.97M	Sell	23,916 -1,568	-6%	-$140K	1.04%	8
2015 Q2	$2.24M	Sell	25,484 -4,109	-14%	-$377K	1.04%	13
2015 Q1	$2.61M	Sell	29,593 -4,619	-14%	-$410K	1.04%	14
2014 Q4	$2.84M	Sell	34,212 -2,290	-6%	-$190K	1.14%	15
2014 Q3	$3.08M	Sell	36,502 -2,123	-5%	-$172K	1.15%	15
2014 Q2	$3.13M	Buy	38,625 +333	+0.9%	+$26.2K	0.97%	19
2014 Q1	$2.92M	Buy	38,292 +135	+0.4%	+$9.84K	0.96%	19
2013 Q4	$2.75M	Buy	38,157 +15,782	+71%	+$1.1M	0.94%	27
2013 Q3	$1.54M	Sell	22,375 -1,163	-5%	-$76.9K	0.62%	40
2013 Q2	$1.5M	Buy	+23,538	New	+$1.53M	0.63%	43

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Shamrock Asset Management's NVS Position: Q3 2019 in Review

Shamrock Asset Management reduced its Novartis (NVS) stake by 2.6% in Q3 2019, selling an estimated $22.5K and leaving 9,307 shares worth $809K. The position accounts for 0.63% of the portfolio, ranked #42.

Shamrock Asset Management first reported a position in NVS in Q2 2013 and has held it in 26 quarters since. The position peaked at $3.13M in Q2 2014. 1,090 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

Shamrock Asset Management held 9,307 shares of Novartis worth $809K as of Q3 2019.
Shamrock Asset Management sold 251 Novartis shares in Q3 2019, an estimated $22.5K.
Novartis made up 0.63% of Shamrock Asset Management's portfolio in Q3 2019, its #42 holding.
Shamrock Asset Management first reported a position in Novartis in Q2 2013 and has held it in 26 quarters since.
Shamrock Asset Management's Novartis position peaked at $3.13M in Q2 2014.
1,090 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.